Maximus, Inc. (NYSE:MMS – Get Free Report) declared a quarterly dividend on Tuesday, January 6th. Shareholders of record on Friday, February 13th will be paid a dividend of 0.33 per share by the health services provider on Monday, March 2nd. This represents a c) dividend on an annualized basis and a yield of 1.5%. The ex-dividend date of this dividend is Friday, February 13th. This is a 10.0% increase from Maximus’s previous quarterly dividend of $0.30.
Maximus has raised its dividend payment by an average of 0.0%per year over the last three years and has increased its dividend every year for the last 2 years. Maximus has a dividend payout ratio of 18.0% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Maximus to earn $5.76 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 20.8%.
Maximus Stock Down 0.9%
Shares of Maximus stock opened at $89.00 on Wednesday. The stock has a market capitalization of $4.85 billion, a price-to-earnings ratio of 16.01 and a beta of 0.56. Maximus has a twelve month low of $63.77 and a twelve month high of $92.50. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.77. The business’s 50 day simple moving average is $84.86 and its 200-day simple moving average is $82.82.
Insider Buying and Selling
In other Maximus news, insider Michelle F. Link sold 4,039 shares of Maximus stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total transaction of $350,746.76. Following the transaction, the insider directly owned 19,542 shares in the company, valued at approximately $1,697,027.28. The trade was a 17.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.60% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of MMS. Norges Bank acquired a new stake in Maximus during the second quarter valued at $47,886,000. Boston Partners raised its holdings in Maximus by 113.6% during the second quarter. Boston Partners now owns 657,247 shares of the health services provider’s stock valued at $46,435,000 after buying an additional 349,529 shares in the last quarter. River Road Asset Management LLC acquired a new stake in shares of Maximus in the second quarter worth about $18,073,000. Stephens Investment Management Group LLC lifted its position in shares of Maximus by 49.0% in the third quarter. Stephens Investment Management Group LLC now owns 720,943 shares of the health services provider’s stock worth $65,873,000 after buying an additional 237,097 shares during the last quarter. Finally, Voya Investment Management LLC boosted its stake in shares of Maximus by 1,380.3% during the 3rd quarter. Voya Investment Management LLC now owns 228,488 shares of the health services provider’s stock worth $20,877,000 after acquiring an additional 213,053 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.
About Maximus
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
See Also
- Five stocks we like better than Maximus
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- Punch these codes into your ordinary brokerage account
- You Still Think Silver’s a Joke? Watch What Happens Next.
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
